Back
Hartford US Quality Growth ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
68
HQGO
Hartford US Quality Growth ETF
Last Price:
$52.97
Seasonality Move:
7.36%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$37.84
Seasonality Move:
16.74%
Buy
68
Hartford US Quality Growth ETF (HQGO)
is a Buy
Is Hartford US Quality Growth ETF a Buy, Sell or Hold?
-
The current Hartford US Quality Growth ETF [HQGO] share price is $53.19. The Score for HQGO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
HQGO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $37.81. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HQGO Stock Price Chart
What is Hartford US Quality Growth ETF's stock price today?
-
The Hartford US Quality Growth ETF share price today is $53.19The current trend is moderately bullish and HQGO is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $37.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
HQGO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 64.26 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.15 - 53.11) | Buy |
| Bollinger Bands (100): | (48.24 - 53.86) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.78 | Sell |
| Relative Strength Index (14 RSI): | 38.88 | Sell |
| Chaikin Money Flow: | -2241721 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.35 - 39.73) | Sell |
| Bollinger Bands (100): | (44.55 - 105.49) | Sell |
HQGO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.9 | Buy |
| 20-day SMA: | 52.48 | Buy |
| 50-day SMA: | 49.81 | Buy |
| 200-day SMA: | 51.35 | Buy |
| 8-day EMA: | 52.91 | Buy |
| 20-day EMA: | 52.22 | Buy |
| 50-day EMA: | 51.14 | Buy |
| 200-day EMA: | 50.42 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.37 | Sell |
| 20-day SMA: | 38.44 | Sell |
| 50-day SMA: | 47.63 | Sell |
| 200-day SMA: | 100.07 | Sell |
| 8-day EMA: | 39.16 | Sell |
| 20-day EMA: | 40.5 | Sell |
| 50-day EMA: | 50.9 | Sell |
| 200-day EMA: | 88.45 | Sell |
Hartford US Quality Growth ETF Earnings Growth & HQGO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.74 per share, an increase next quarter of $0.95 per share, a decrease this year of $3.92 per share, and an increase next year of $7.74 per share.
Hartford US Quality Growth ETF Technical Analysis
| May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||